Substance abuse in patients with attention-deficit hyperactivity disorder: Therapeutic implications

CNS Drugs

Volumn 19, Issue 8, 2005, Pages 643-655

  Schubiner, Howard ^a,b  

^a PROVIDENCE HOSPITAL   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; AMPHETAMINE; ANTIDEPRESSANT AGENT; ATOMOXETINE; CENTRAL STIMULANT AGENT; COCAINE; DESIPRAMINE; DEXAMPHETAMINE; METHYLPHENIDATE; PEMOLINE; VENLAFAXINE;

ANXIETY DISORDER; ATTENTION DEFICIT DISORDER; BEHAVIOR; BEHAVIOR THERAPY; BLOOD PRESSURE MEASUREMENT; CLINICAL TRIAL; COCAINE DEPENDENCE; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; DISORIENTATION; HEALTH PROGRAM; HUMAN; INSOMNIA; INTERVIEW; MEDICAL RESEARCH; MONITORING; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RECURRENT DISEASE; REVIEW; RISK REDUCTION; SAFETY; SUBSTANCE ABUSE; ADDICTION; PSYCHIATRIC DIAGNOSIS;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; DIAGNOSIS, DUAL (PSYCHIATRY); HUMANS; SUBSTANCE-RELATED DISORDERS;

EID: 24144458631     PISSN: 11727047     EISSN: None     Source Type: Journal    
DOI: 10.2165/00023210-200519080-00001     Document Type: Review

References (105)

1. Faraone SV, Biederman J. Neurobiology of attention-deficit hyperactivity disorder. Biol Psychiatry 1998; 44 (10): 951-8
2. Faraone SV. Genetics of adult attention-deficit/hyperactivity disorder. Psychiatr Clin North Am 2004; 27: 303-21
3. Biederman J, Faraone SV. Attention deficit hyperactivity disorder: a worldwide concern. J Nerv Ment Dis 2004; 192 (7): 453-4
4. Barbaresi WJ, Katusic SK, Colligan RC, et al. How common is attention-deficit/hyperactivity disorder? Arch Pediatr Adolesc Med 2002; 156: 217-24
5. Adler L, Cohen J. Diagnosis and evaluation of adults with attention-deficit/hyperactivity disorder. Psychiatr Clin North Am 2004; 27: 187-201
6. Barkley R. Attention-deficit hyperactivity disorder: a handbook for diagnosis and treatment. 2nd ed. New York (NY): Guilford Press, 1998
7. Biederman J, Faraone S, Milberger S, et al. A prospective 4-year follow-up study of attention-deficit hyperactivity and related disorders. Arch Gen Psychiatry 1996; 53: 437-46
8. Weiss G, Hechtman L. Hyperactive children grown up: ADHD in children, adolescents, and adults. New York (NY): Guilford Press, 1993
9. Faraone SV, Biederman J, Spencer T, et al. Attention-deficit/ hyperactivity disorder in adults: an overview. Biol Psychiatry 2000; 48: 9-20
10. Murphy K, Barkley RA. Prevalence of DSM-IV symptoms of ADHD in adult licensed drivers: implications for clinical diagnosis. J Atten Disord 1996; 1 (3): 147-61
11. Weiss M, Murray C. Assessment and management of attention-deficit/ hyperactivity disorder in adults. CMAJ 2003; 168 (6): 715-22
12. Biederman J, Newcorn J, Sprich S. Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders. Am J Psychiatry 1991; 148: 564-77
13. Biederman J, Wilens TE, Mick E, et al. Psychoactive substance use disorders in adults with attention deficit hyperactivity disorder: effects of ADHD and psychiatric comorbidity. Am J Psychiatry 1995; 152: 1652-8
14. Biederman J, Faraone SV, Spencer T, et al. Patterns of psychiatric comorbidity, cognition, and psychosocial functioning in adults with attention-deficit/hyperactivity disorder. Am J Psychiatry 1993; 150 (12): 1792-8
15. ADHD: a public health perspective. Centers for Disease Control and Prevention [online]. Available from URL: http://www.cdc.gov/ncbddd/adhd/ publichealth.htm [Accessed 2005 Feb 11]
16. Kluger J. Are we giving our kids too many drugs? Time 2003 Nov 3
17. Breggin PR, Baughman FA. Questioning the treatment for ADHD. Science 2001; 291: 595
18. Citizen's commission on human rights 1996-2005. Psychiatry: betraying and drugging children [online]. Available from URL: http://www.cchr.org/children [Accessed 2004 Dec 10]
19. Jensen PS, Kettle L, Roper MT, et al. Are stimulants over-prescribed? Treatment of ADHD in four US communities. J Am Acad Child Adolesc Psychiatry 1999 Jul; 38 (7): 797-804
20. Zito JM, dos Reis S, Gardner JF, et al. Trends in the prescribing of psychotropic medications to preschoolers. JAMA 2000; 283: 1025-30
21. Halikas J, Melles J, Morse C, et al. Predicting substance abuse in juvenile offenders: ADD versus aggressivity. Child Psychiatry Hum Dev 1990; 21: 49-55
22. Thompson LL, Riggs PD, Mikulich SK, et al. Contribution of ADHD symptoms to substance problems and delinquency in conduct-disordered adolescents. J Abnorm Child Psychol 1996; 24: 325-47
23. DeMilio L. Psychiatric syndromes in adolescent substance abusers. Am J Psychiatry 1989; 146: 1212-4
24. Milin R, Halikas JA, Meller JE, et al. Psychopathology among substance abusing juvenile offenders. J Am Acad Child Adolesc Psychiatry 1991; 30 (4): 569-74
25. Wilens TE, Biederman J, Mick E, et al. Attention deficit hyper-activity disorder (ADHD) is associated with early onset substance use disorders. J Nerv Ment Dis 1997; 185: 475-82
26. Lynskey MT, Fergusson DM. Childhood conduct problems and attention deficit behaviours and adolescent alcohol, tobacco and illicit drug use. J Abnorm Child Psychol 1995; 23: 281-302
27. Disney ER, Elkins IJ, McGue M, et al. Effects of ADHD, conduct disorder, and gender on substance use and abuse in adolescence. Am J Psychiatry 1999; 156: 1515-21
28. Greenbaum PE, Prange ME, Friedman RM, et al. Substance abuse prevalence and comorbidity with other psychiatric disor-ders among adolescents with severe emotional disturbances. J Am Acad Child Adolesc Psychiatry 1991; 30: 575-83
29. Milberger S, Biederman J, Faraone SV, et al. Associations between ADHD and psychoactive substance use disorders: findings from a longitudinal study of high-risk siblings of ADHD children. Am J Addict 1997; 6 (4): 318-29
30. Shekim WO, Asarnow RF, Hess E, et al. A clinical and demographic profile of a sample of adults with ADHD, residual state. Compr Psychiatry 1990; 31: 416-25
31. Wilens T, Spencer T, Biederman J. Are attention deficit hyperactivity disorder and psychoactive substance use disorders really related? Harv Rev Psychiatry 1995; 3: 260-2
32. Biederman J, Wilens TE, Mick E, et al. Does ADHD impact the developmental course of drug and alcohol abuse and dependence? Biol Psychiatry 1998; 44: 269-73
33. Carroll KM, Rounsaville BJ. History and significance of childhood attention deficit disorder in treatment-seeking cocaine abusers. Compr Psychiatry 1993; 34: 75-82
34. Levin FR, Evans SM, Kleber HD. Prevalence of adult ADHD among cocaine abusers seeking treatment. Drug Alcohol Depend 1998; 52: 15-25
35. Schubiner H, Tzelepis A, Milberger S, et al. Prevalence of ADHD and conduct disorder among substance abusers. J Clin Psychiatry 2000; 61: 244-51
36. Goodwin DW, Schulsinger F, Hermansen L, et al. Alcoholism and the hyperactive child syndrome. J Nerv Ment Dis 1975; 160 (5): 349-53
37. Mannuzza S, Klein R, Bessler A, et al. Adult psychiatric status of hyperactive boys grown up: V. Replication of adult status. Arch Gen Psychiatry 1991; 48: 77-83
38. Flory K, Milich R, Lynam DR, et al. Relation between childhood disruptive behavior disorders and substance use and dependence symptoms in young adulthood: individuals with symptoms of ADHD and conduct disorder are uniquely at risk. Psychol Addict Behav 2003; 17 (2): 151-8
39. Loeber R, Brinthaupt VP, Green SM. Attention deficits, impulsivity, and hyperactivity with or without conduct problems: relationships to delinquency and unique contextual factors. In: RJ McMahon, RD Peters, editors. Behavior disorders of adolescence: research, intervention, and policy in clinical and school settings. New York (NY): Plenum, 1990: 39-61
40. Molina BSG, Bukstein OG, Lynch KG. ADHD and conduct disorder symptomatology in adolescents with alcohol use disorder. Psychol Addict Behav 2002; 16 (2): 161-4
41. Biederman J, Wilens T, Mick E, et al. Is ADHD a risk for psychoactive substance use disorder? Findings from a four year follow up study. J Am Acad Child Adolesc Psychiatry 1997; 36: 21-9
42. Wilens TE, Biederman J, Millstein R, et al. Risk for substance use disorders in youths with child- and adolescent-onset bipolar disorder. J Am Acad Child Adolesc Psychiatry 1999; 38 (6): 680-5
43. Geller B, Cooper T, Sun K, et al. Double-blind and placebo controlled study of lithium for adolescent bipolar disorders with secondary substance dependency. J Am Acad Child Adolesc Psychiatry 1998; 37: 171-8
44. Wilens T, Biederman J, Mick E. Does ADHD affect the course of substance abuse? Findings from a sample of adults with and without ADHD. Am J Addict 1998; 7: 156-63
45. Whitmore EA, Mikulich SK, Thompson LL, et al. Influences on adolescent substance dependence: conduct disorder, depression, attention deficit hyperactivity disorder, and gender. Drug Alcohol Depend 1997; 47: 87-97
46. Seidman LJ, Doyle A, Fried R, et al. Neuropsychological function in adults with attention-deficit/hyperactivity disorder. Psychiatr Clin North Am 2004; 27: 261-82
47. Kandel DB, Logan JA. Patterns of drug use from adolescence to young adulthood: I. Periods of risk for initiation, continued use, and discontinuation. Am J Public Health 1984; 74 (7): 660-6
48. Yamaguchi K, Kandel DB. Patterns of drug use from adolescence to young adulthood. III: Predictors of progression. Am J Public Health 1984; 74 (7): 673-81
49. Mannuzza S, Gittelman-Klein R, Konig PH, et al. Hyperactive boys almost grown up. IV: Criminality and its relationship to psychiatric status. Arch Gen Psychiatry 1989; 46: 1073-9
50. Wilens TE. Attention-deficit/hyperactivity disorder and the substance use disorders: the nature of the relationship, subtypes at risk, and treatment issues. Psychiatr Clin North Am 2004; 27: 283-301
51. Jadad AR, Boyle M, Cunningham C, et al. Treatment of attention-deficit/ hyperactivity disorder: evidence report/technology assessment No. 11. Rockville (MD): Agency for Healthcare Research and Quality, 1999: 1-341
52. Spencer TJ, Biederman J, Wilens T, et al. Pharmacotherapy of attention deficit hyperactivity disorder across the lifecycle: a literature review. J Am Acad Child Adolesc Psychiatry 1996; 35: 409-32
53. The MTA Cooperative Group. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group Multimodal Treatment Study of Children with ADHD. Arch Gen Psychiatry 1999; 56: 1073-86
54. Daley KC. Update on attention-deficit/hyperactivity disorder. Curr Opin Pediatr 2004 Apr; 16 (2): 217-26
55. American Academy of Pediatrics. Clinical practice guideline: diagnosis and evaluation of the child with attention-deficit/hyperactivity disorder. Pediatrics 2000 May; 105 (5): 1158-70
56. Spencer T, Biederman J, Wilens T. Stimulant treatment of adult attention-deficit/hyperactivity disorder. Psychiatr Clin N Am 2004; 27: 361-72
57. Gualtiere CT, Wargin W, Kanoy R, et al. Clinical studies of methylphenidate serum levels in children and adults. J Am Acad Child Psychiatry 1982; 21: 19-26
58. Mattes JA, Boswell J, Oliver H. Methylphenidate effects on symptoms of attention deficit disorder in adults. Arch Gen Psychiatry 1984; 41: 449-56
59. Wender PH, Reimherr F, Wood D. A controlled study of methylphenidate in the treatment of attention deficit disorder, residual type, in adults. Am J Psychiatry 1985; 142: 547-52
60. Spencer T, Wilens T, Biederman J, et al. A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood onset ADHD. Arch Gen Psychiatry 1995; 52: 434-43
61. Spencer T, Biederman J, Wilens T, et al. Efficacy of a mixed amphetamine salts compound in adults with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 2001 Aug; 58 (8): 775-82
62. Weisler R, Chrisman AK, Wilens T. Adderall XR dosed once daily in adults patients with ADHD [abstract]. The Annual Meeting of the American Psychiatric Association; 2003 Oct 20; San Francisco (CA)
63. Wilens TE, Biederman J, Prince J, et al. Six week, double-blind, placebo-controlled study of desipramine for adult attention deficit hyperactive disorder. Am J Psychiatry 1996; 153: 1147-53
64. Wilens TE, Spencer TJ, Biederman J, et al. A controlled clinical trial of bupropion for attention-deficit/hyperactivity disorder. Am J Psychiatry 2001; 158: 282-8
65. Michelson D, Adler L, Spencer T, et al. Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies. Biol Psychiatry 2003 Jan 15; 53 (2): 112-20
66. Spencer T, Biederman J, Wilens T, et al. Effectiveness and tolerability of tomoxetine in adults with attention-deficit/hyperactivity disorder. Am J Psychiatry 1998; 155: 693-5
67. Huss M, Lehmkuhl U. Methylphenidate and substance abuse: a review of pharmacology, animal and clinical studies. J Atten Disord 2002; 6: S65-71
68. Robbins TW, Everitt BJ. Drug addiction: bad habits add up. Nature 1999; 398: 567-70
69. Kollins SH, MacDonald EK, Rush CR. Assessing the abuse potential of methylphenidate in nonhuman and human subjects: a review. Pharmacol Biochem Behav 2001; 68: 611-27
70. Volkow ND, Ding Y, Fowler JS, et al. Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in the human brain. Arch Gen Psychiatry 1995; 52: 456-63
71. Volkow ND, Wang GJ, Fowler JS, et al. Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate. Am J Psychiatry 1998; 155: 1325-31
72. Klein-Schwartz W. Abuse and toxicity of methylphenidate. Curr Opin in Pediatr 2002; 14: 219-23
73. Monitoring the Future. University of Michigan Substance Abuse Research Center [online]. Available from URL: http://www.monitoringthefuture.org [Accessed 2005 Feb 11]
74. Babcock Q, Byrne T. Student perceptions of methylphenidate abuse at a public liberal arts college. J Am Coll Health 2000; 49: 143-5
75. Low KG, Gendaszek AE. Illicit use of psychostimulants among college students: a preliminary study. Psychology, Health and Medicine 2002; 7 (3): 283-7
76. Poulin C. Medical and nonmedical stimulant use among adolescents: from sanctioned to unsanctioned use. CMAJ 2001; 165 (8): 1039-44
77. Jaffe SL. Failed attempts at intranasal abuse of Concerta [letter]. J Am Acad Child Adolesc Psychiatry 2002; 41: 5
78. Ciccone PE. Attempted abuse of Concerta [letter]. J Am Acad Child Adolesc Psychiatry 2002; 41: 756
79. Wilens T, Faraone S, Biederman J, et al. Does stimulant therapy of ADHD beget later substance abuse: a meta-analytic review of the literature. Pediatrics 2003; 11 (1): 179-85
80. Milin R, Loh E, Chow J, et al. Assessment of symptoms of attention-deficit hyperactivity disorder in adults with substance use disorders. Psychiatr Serv 1997; 48: 1378-80
81. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. American Psychiatric Association, Washington, DC: 1994
82. Adler LA, Kessler RC, Spencer T. The adult ADHD self-report scale (ASRS-v1.1) symptom checklist: World Health Organisation 2002 [online]. Available from URL: http://www.med.nyu.edu/psych/assets/adhdscreen18.pdf [Accessed 2004 Dec 10]
83. Conners CK, Erhardt JN, Epstein D, et al. Conners adult self-rating of ADHD symptoms in adults I: factor structure and normative data. J Atten Disord 1999; 3 (3): 141-51
84. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed., text rev. Washington, DC: American Psychiatric Press, 2000
85. Schubiner H, Tzelepis A, Isaacson JH, et al. The dual diagnosis of attention-deficit/hyperactivity disorder and substance abuse: case reports and literature review. J Clin Psychiatry 1995 Apr; 56 (4): 146-50
86. Khantzian EJ. The self-medication hypothesis of substance use disorders: a reconsideration and recent applications. Harv Rev Psychiatry 1997 Jan-Feb; 4 (5): 231-44
87. Levin FR, Evans SM, McDowell DM, et al. Methylphenidate treatment for cocaine abusers with adult attention-deficit/hyperactivity disorder: a pilot study. J Clin Psychiatry 1998; 59: 300-5
88. Castaneda R, Levy R, Hardy M, et al. Long-acting stimulants for the treatment of attention-deficit disorder in cocaine-dependent adults. Psychiatr Serv 2000; 51 (2): 169-71
89. Grabowski J, Rhoades H, Schmitz J, et al. Dextroamphetamine for cocaine-dependence treatment: a double-blind randomized clinical trial. J Clin Psychopharmacol 2001; 21: 522-6
90. Grabowski J, Roache JD, Schmitz J, et al. Replacement medication for cocaine dependence: methylphenidate. J Clin Psychopharmacol 1997; 17: 485-8
91. Roache JD, Grabowski J, Schmitz JM, et al. Laboratory measures of methylphenidate effects in cocaine-dependent patients receiving treatment. J Clin Psychopharmacol 2000; 20: 61-8
92. Schubiner H, Saules KK, Arfken CL, et al. Double-blind placebo-controlled trial of methylphenidate in the treatment of adult ADHD patients with comorbid cocaine dependence. Exp Clin Psychopharmacol 2002; 10 (3): 286-94
93. McClellan AT, Luborsky L, Cacciola J, et al. New data from the addiction severity index: reliability and validity in three centers. J Nerv Ment Dis 1985; 173: 412-23
94. Tiffany ST, Singleton E, Haertzen CA, et al. The development of a cocaine craving questionnaire. Drug Alcohol Depend 1993; 34: 19-28
95. Beck AT, Ward CH, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry 1961; 4: 561-71
96. Wilens TE, Biederman J, Spencer T, et al. Controlled trial of high doses of pemoline for adults with attention-deficit/hyperactivity disorder. J Clin Psychopharmacol 1999; 19: 257-64
97. Wilens TE, Biederman J, Spencer T, et al. Controlled trial of high doses of pemoline for adults with attention-deficit/hyperactivity disorder. J Clin Psychopharmacol 1999; 19: 257-64
98. Johnston C, Leung DW. Effects of medication, behavioral, and combined treatments on parents' and children's attributions for the behavior of children with attention-deficit hyperactivity disorder. J Consult Clin Psychol 2001; 69: 67-76
99. Murphy KR. Empowering the adult with ADHD. In: KG Nadeau, editor. A comprehensive guide for attention deficit disorder in adults: research, diagnosis, and treatment. New York (NY): Brunner/Mazel, 1995: 135-45
100. Searight HR, Burke JM, Rottnek F. Adult ADHD: evaluation and treatment in family medicine. Am Fam Physician 2000; 62: 2077-86
101. Levin FR, Evans SM, Kleber HD. Practical guidelines for the treatment of substance abusers with adult attention-deficit hyperactivity disorder. Psychiatr Serv 1999; 50 (8): 1001-3
102. Riggs P. Clinical approach to treatment of ADHD in adolescents with substance use disorders and conduct disorder. J Am Acad Child Adolesc Psychiatry 1998; 37 (3): 331-2
103. Heil SH, Holmes HW, Bickel WK, et al. Comparison of the subjective, physiological, and spychomotor effects of atomoxetine and methylphenidate in light drug users. Drug Alcohol Depend 2002; 67: 149-56
104. Michelson D, Adler L, Spencer T, et al. Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies. Biol Psychiatry 2003; 53: 112-20
105. Spencer T, Biederman J, Wilens T, et al. Effectiveness and tolerability of tomoxetine in adults with attention deficit hyperactivity disorder. Am J Psychiatry 1998; 155: 693-5